Humanigen
Humanigen is a biopharmaceutical company that develops and commercializes monoclonal antibody therapeutics for the treatment of cancer and infectious diseases.
Business Model:
Revenue: $3.1M
Employees: 2-10
Industries / Tags:
Detailed Humanigen Information
Geographic Data
Address: 533 Airport Blvd
City: Burlingame
State: CA
Zip: 94010
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$93M
Raised Total:$254M
Social
Metrics
3,091,028Website Global Rank
5,445Website Monthly Traffic
Twitter Followers
Description
Humanigen is a biopharmaceutical company that develops and commercializes monoclonal antibody therapeutics for the treatment of cancer and infectious diseases.
Contact Phone:
+16502433100
Contact Email:
Humanigen went public on 8/7/2017 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
8/7/2017
Ticker Symbol:
HGEN
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
